Potential Phytochemicals of Smilax zeylanica for Treatment of Brain Disorders

Abstract

Neurological disorders are described as conditions characterized by the systematic death of neurons. Conventional and newer molecules have been studied, but they only provide symptomatic benefits and come with a slew of adverse effects. The current vision will be the development of more convincing molecules that will interrupt the progression of such disorders. There are many synthetic drugs available, but they may cause a variety of other health problems. As a result, natural molecules derived from plants and other materials are being found to supplement existing medications. The WHO recommends that people increase their consumption of foods, herbs, and fibers as a way to lower their risk of neurodegenerative diseases. Chemically synthesized molecules can be replaced by phytochemicals from medicinal plants, which are a healthier and safer substitute. Smilax zeylanica contains polyphenols, flavonoids, phenolic compounds, tannins, alkaloids, and phenylpropanoids glucosides, according to phytochemical reports. The current article examines the effectiveness of Smilax zeylanica, a plant that could have therapeutic value for a variety of neurological disorders such as Parkinson's disease, Alzheimer's disease, Huntington's disease, convulsions, schizophrenia, and stroke